| Description |
1 online resource (674 pages) |
| Series |
Updates in Hypertension and Cardiovascular Protection |
|
Updates in hypertension and cardiovascular protection.
|
| Contents |
Intro; Foreword; Preface; Contents; Part I: Epidemiology and Statistics; 1: High-Normal Blood Pressure in Children and Adolescents; 1.1 Introduction; 1.2 Idea of Prehypertension; 1.3 Classification of Blood Pressure Status in Children and Adolescents: Definition of High-Normal Blood Pressure/Prehypertension in Children and Adolescents; 1.4 Prevalence of High-Normal BP and Hypertension in Children and Adolescents; 1.5 Intermediate Clinical and Laboratory Phenotype of High-Normal BP/Prehypertension in Children; 1.6 Evolution of High-Normal Blood Pressure/Prehypertension in Childhood |
|
1.7 High-Normal Blood Pressure/Prehypertension in Childhood and Risk of Hypertensive Target Organ Damage1.8 Risk of High-Normal BP/Prehypertension in Adolescence and Target Organ Damage and Cardiovascular Disease in Adulthood; 1.9 How to Manage High-Normal Blood Pressure in Children and Adolescents; 1.10 High-Normal Blood Pressure/Prehypertension in Children with Chronic Kidney Disease and Diabetic Children; 1.11 Summary and Perspectives; References; 2: History of Prehypertension: Past and Present, a Saga of Misunderstanding and Neglect; References |
|
3: Parental History of Hypertension as the Determinant of Cardiovascular Function3.1 Blood Pressure; 3.2 Heart and Vessels; 3.3 Biochemical Disturbances and Life Style; 3.4 Cardiovascular Regulation; 3.5 Impact of Hypertensive Disorders of Pregnancy; References; 4: Prehypertension, the Risk of Hypertension and Events; 4.1 Introduction; 4.2 Progression from Prehypertension to Hypertension; 4.2.1 The Progression Process; 4.2.2 Attenuation or Delay of Progression; 4.3 Prehypertension and CV Morbidity; 4.4 Prehypertension and Chronic Kidney Disease (CKD) |
|
4.5 Prehypertension and CV and All-Cause Mortality4.6 Critical Evaluation; References; 5: Prehypertension and the Cardiometabolic Syndrome; 5.1 Definitions of Prehypertension; 5.2 Strategies for Prevention of Hypertension; 5.2.1 Nonpharmacological Approaches; 5.2.2 Pharmacological Approaches; 5.3 Early Detection of Prehypertension: Weight, Metabolic Syndrome, and Reduced eGFR; 5.4 The Cardiovascular Metabolic Syndrome; 5.5 Pathophysiological Markers to Detect Risk for Prehypertension; References; 6: Prehypertension: Definition and Epidemiology; 6.1 Definition of Prehypertension |
|
6.2 Diagnosis of Prehypertension6.3 Epidemiology of Prehypertension; 6.3.1 Prevalence; 6.3.2 Distribution of Prehypertension by Age, Sex, and Race or Ethnicity; 6.3.3 Incidence; 6.3.4 Associated Risk Factors; References; 7: Prehypertension, Statistics and Health Burden; 7.1 Introduction; 7.2 Prevalence of Prehypertension; 7.2.1 Prevalence of Prehypertension in Population-Based Studies; 7.2.2 Prevalence of Prehypertension in Selected Populations; 7.2.3 Prevalence of Prehypertension Based on Meta-Analyses; 7.3 Risk of Incident Hypertension; 7.4 Health Burden |
| Summary |
This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines. While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions - especially when multiple - are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation. In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease. The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases |
| Notes |
7.4.1 Prehypertension and Cardiovascular Risk |
|
Print version record |
| Subject |
Hypertension.
|
|
Metabolic syndrome.
|
|
Cardiovascular system -- Diseases.
|
|
Prehypertension
|
|
Metabolic Syndrome
|
|
Cardiovascular Diseases
|
|
Hypertension
|
|
Metabolic syndrome
|
|
Cardiovascular system -- Diseases
|
|
Hypertension
|
| Form |
Electronic book
|
| Author |
Zimlichman, Reuven, editor
|
|
Julius, Stevo, editor
|
|
Mancia, Giuseppe, editor
|
| ISBN |
9783319753102 |
|
331975310X |
|
